Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007).

作者: Romain Micol , Philippe Buchy , Gilles Guerrier , Veasna Duong , Laurent Ferradini

DOI: 10.1097/QAI.0B013E3181A254C2

关键词:

摘要: Background: In developing countries, the study of cytomegalovirus (CMV) coinfection in HIV-infected patients remains neglected. Quantitative CMV polymerase chain reaction (PCR) is gold standard diagnostic tool for analyzing serum replication and predicting disease. We estimated prevalence replicating sera newly diagnosed Cambodian examined its impact on mortality. Methods: This cohort was based 2 highly active antiretroviral therapy treatment programs Cambodia between 2004 2007. PCR performed baseline samples 377 patients. Results: The DNA 55.2% (150 272) with CD4 + count <100/mm 3 . multivariate analysis, hemoglobin <9 g/dL, CD4' , Karnofsky index <50 were independently associated positive at baseline. During a 3-year follow-up period, viral load ≥3.1 log 10 copies per milliliter significantly death count, other opportunistic infections, therapy. Conclusions: As industrialized prevalent among increased underscores importance infection by < 100/mm treating this to reduce

参考文章(20)
Romain Micol, Olivier Lortholary, Borann Sar, Didier Laureillard, ChanChhaya Ngeth, Jean-Philippe Dousset, Hak Chanroeun, Laurent Ferradini, Philippe Jean Guerin, Fran??oise Dromer, Arnaud Fontanet, Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients Journal of Acquired Immune Deficiency Syndromes. ,vol. 45, pp. 555- 559 ,(2007) , 10.1097/QAI.0B013E31811ED32C
D.A. Wohl, M.A. Kendall, S. Owens, G. Holland, M. Nokta, S.A. Spector, R. Schrier, S. Fiscus, M. Davis, M.A. Jacobson, J.S. Currier, K. Squires, B. Alston-Smith, J. Andersen, W.R. Freeman, M. Higgins, F.J. Torriani, , The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. Hiv Clinical Trials. ,vol. 6, pp. 136- 146 ,(2005) , 10.1310/4J65-4YX1-4ET6-E5KR
E Frances Bowen, Caroline A. Sabin, Pauline Wilson, Paul D. Griffiths, Clare C. Davey, Margaret A. Johnson, Vincent C. Emery, Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS. ,vol. 11, pp. 889- 893 ,(1997) , 10.1097/00002030-199707000-00008
Petros I Rafailidis, Eleni G Mourtzoukou, Ioannis C Varbobitis, Matthew E Falagas, Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virology Journal. ,vol. 5, pp. 47- 47 ,(2008) , 10.1186/1743-422X-5-47
David A Wohl, Donglin Zeng, Paul Stewart, Nicolas Glomb, Timothy Alcorn, Suzanne Jones, Jean Handy, Susan Fiscus, Adriana Weinberg, Deepthiman Gowda, Charles van der Horst, Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. Journal of Acquired Immune Deficiency Syndromes. ,vol. 38, pp. 538- 544 ,(2005) , 10.1097/01.QAI.0000155204.96973.C3
M.A. French, N. Lenzo, M. John, S.A. Mallal, E.J. McKinnon, I.R. James, P. Price, J.P. Flexman, M-L. Tay-Kearney, Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy Hiv Medicine. ,vol. 1, pp. 107- 115 ,(2000) , 10.1046/J.1468-1293.2000.00012.X
K. K. Hansen, A. Ricksten, B. Hofmann, B. Norrild, S. Olofsson, L. Mathiesen, Detection Of Cytomegalovirus Dna In Serum Correlates With Clinical Cytomegalovirus Retinitis in AIDS The Journal of Infectious Diseases. ,vol. 170, pp. 1271- 1274 ,(1994) , 10.1093/INFDIS/170.5.1271
Sergio Reus, Joaquín Portilla, Adelina Gimeno, José Sánchez-Payá, JA García-Henarejos, Onofre Martínez-Madrid, Jordi Usó, Bernardino Roca, María José Galindo, José López-Aldeguer, grupo de estudio IRENE, None, Predictores de progresión y muerte en pacientes con infección avanzada por el VIH en la era de los tratamientos antirretrovirales de gran actividad Enfermedades Infecciosas Y Microbiologia Clinica. ,vol. 22, pp. 142- 149 ,(2004) , 10.1016/S0213-005X(04)73054-2